Shandong Jincheng Pharmaceutical Group Co., Ltd

XSEC:300233 Stock Report

Market Cap: CN¥4.9b

Shandong Jincheng Pharmaceutical Group Balance Sheet Health

Financial Health criteria checks 5/6

Shandong Jincheng Pharmaceutical Group has a total shareholder equity of CN¥3.8B and total debt of CN¥592.4M, which brings its debt-to-equity ratio to 15.7%. Its total assets and total liabilities are CN¥5.6B and CN¥1.8B respectively. Shandong Jincheng Pharmaceutical Group's EBIT is CN¥221.2M making its interest coverage ratio 54.1. It has cash and short-term investments of CN¥941.3M.

Key information

15.7%

Debt to equity ratio

CN¥592.43m

Debt

Interest coverage ratio54.1x
CashCN¥941.29m
EquityCN¥3.76b
Total liabilitiesCN¥1.84b
Total assetsCN¥5.60b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 300233's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥1.3B).

Long Term Liabilities: 300233's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥501.9M).


Debt to Equity History and Analysis

Debt Level: 300233 has more cash than its total debt.

Reducing Debt: 300233's debt to equity ratio has increased from 11.6% to 15.7% over the past 5 years.

Debt Coverage: 300233's debt is well covered by operating cash flow (68.3%).

Interest Coverage: 300233's interest payments on its debt are well covered by EBIT (54.1x coverage).


Balance Sheet


Discover healthy companies